-
Product Insights
Likelihood of Approval Analysis for Psoriatic Arthritis
Overview How likely is it that the drugs in Psoriatic Arthritis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psoriatic Arthritis Overview Psoriatic arthritis is a form of arthritis that affects...
-
Product Insights
Likelihood of Approval Analysis for Tetanus
Overview How likely is it that the drugs in Tetanus will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tetanus Overview Tetanus is a serious illness caused by Clostridium bacteria. Signs and...
-
Product Insights
Likelihood of Approval Analysis for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
Overview How likely is it that the drugs in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peripheral Arterial Disease (PAD)/ Peripheral Vascular...
-
Product Insights
Likelihood of Approval Analysis for Mycoses
Overview How likely is it that the drugs in Mycoses will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mycoses Overview Mycoses, also known as fungal infections, encompass a diverse group of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EscharEx in Diabetic Foot Ulcers
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EscharEx in Diabetic Foot Ulcers report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EscharEx in Diabetic Foot Ulcers Drug Details: EscharEx is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EscharEx Second Generation in Diabetic Foot Ulcers
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EscharEx Second Generation in Diabetic Foot Ulcers report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EscharEx Second Generation in Diabetic Foot Ulcers Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Incobotulinumtoxin A in Peripheral Neuropathic Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Incobotulinumtoxin A in Peripheral Neuropathic Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Incobotulinumtoxin A in Peripheral Neuropathic Pain Drug Details: Incobotulinumtoxin A...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OQL-011 in Drug Hypersensitivity Reactions
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OQL-011 in Drug Hypersensitivity Reactions report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OQL-011 in Drug Hypersensitivity Reactions Drug Details: OQL011 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sevoflurane in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sevoflurane in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sevoflurane in Pain Drug Details: VPX-638 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FGF-1 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FGF-1 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FGF-1 in Parkinson's Disease Drug Details: FGF-1 is under development for the...